The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 14, 2026 | Blacher Joshua | Co-Chief Financial Officer | Grant(A) | 9K | — | $0 |
| Nov 28, 2025 | Vennare Raymond F | Chief Executive Officer, Director | Tax withholding(F) | 2K | $5.90 | $14K |
| Sep 9, 2025 | Vennare Raymond F | Chief Executive Officer, Director | Grant(A) | 125K | — | $0 |
| Sep 9, 2025 | Blacher Joshua | Interim CFO | Grant(A) | 97K | — | $0 |
| Sep 9, 2025 | Nuzum Charles Lee Sr | Director | Grant(A) | 65K | — | $0 |
| Sep 9, 2025 | ST. Clair Gregory SR | Director | Grant(A) | 65K | — | $0 |
| Sep 9, 2025 | Rao Veena | Director | Grant(A) | 65K | — | $0 |
| Sep 9, 2025 | Hawryluk Matthew | Director | Grant(A) | 65K | — | $0 |
| Sep 9, 2025 | Handley Daniel E | Director | Grant(A) | 65K | — | $0 |
| Sep 9, 2025 | Chung-Welch Nancy | Director | Grant(A) | 65K | — | $0 |
| Apr 5, 2024 | Chung-Welch Nancy | Director | Grant(A) | 2K | — | $0 |
| Apr 5, 2024 | Handley Daniel E | Director | Grant(A) | 2K | — | $0 |
| Apr 5, 2024 | Nuzum Charles Lee Sr | Director | Grant(A) | 3K | — | $0 |
| Apr 5, 2024 | Rao Veena | Director | Grant(A) | 3K | — | $0 |
| Apr 5, 2024 | Hawryluk Matthew | Director | Grant(A) | 2K | — | $0 |
| Apr 5, 2024 | ST. Clair Gregory SR | Director | Grant(A) | 3K | — | $0 |
| Oct 2, 2023 | Nuzum Charles Lee Sr | Director | Grant(A) | 3K | — | $0 |
| Oct 2, 2023 | Hawryluk Matthew | Director | Grant(A) | 2K | — | $0 |
| Oct 2, 2023 | Chung-Welch Nancy | Director | Grant(A) | 2K | — | $0 |
| Oct 2, 2023 | ST. Clair Gregory SR | Director | Grant(A) | 2K | — | $0 |
| Oct 2, 2023 | Handley Daniel E | Director | Grant(A) | 2K | — | $0 |
| Oct 2, 2023 | Rao Veena | Director | Grant(A) | 2K | — | $0 |
| Sep 25, 2023 | Nuzum Charles Lee Sr | Director | Sell(S) | 10K | $3.04 | $30K |
| Sep 25, 2023 | Myers Robert L | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 510 | $2.96 | $2K |
| Sep 25, 2023 | Myers Robert L | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | — | — |
| Jul 3, 2023 | Chung-Welch Nancy | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2023 | Handley Daniel E | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2023 | Hawryluk Matthew | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2023 | Rao Veena | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2023 | ST. Clair Gregory SR | Director | Grant(A) | 4K | — | $0 |
| Jul 3, 2023 | Nuzum Charles Lee Sr | Director | Grant(A) | 4K | — | $0 |
| May 12, 2023 | Rao Veena | Director | Grant(A) | 1K | — | $0 |
| Apr 3, 2023 | Smith David Stewart | Director | Grant(A) | 18K | — | $0 |
| Apr 3, 2023 | Nuzum Charles Lee Sr | Director | Grant(A) | 25K | — | $0 |
| Apr 3, 2023 | Handley Daniel E | Director | Grant(A) | 18K | — | $0 |
| Apr 3, 2023 | Chung-Welch Nancy | Director | Grant(A) | 18K | — | $0 |
| Apr 3, 2023 | ST. Clair Gregory SR | Director | Grant(A) | 25K | — | $0 |
| Apr 3, 2023 | Hawryluk Matthew | Director | Grant(A) | 18K | — | $0 |
| Jan 25, 2023 | Nuzum Charles Lee Sr | Director | Grant(A) | 54K | — | $0 |
| Jan 3, 2023 | Nuzum Charles Lee Sr | Director | Grant(A) | 172K | — | $0 |
| Jan 3, 2023 | Chung-Welch Nancy | Director | Grant(A) | 98K | — | $0 |
| Jan 3, 2023 | ST. Clair Gregory SR | Director | Grant(A) | 100K | — | $0 |
| Jan 3, 2023 | Hawryluk Matthew | Director | Grant(A) | 20K | — | $0 |
| Jan 3, 2023 | Vennare Raymond F | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 59K | — | $0 |
| Jan 3, 2023 | Handley Daniel E | Director | Grant(A) | 63K | — | $0 |
| Jan 3, 2023 | Smith David Stewart | Director | Grant(A) | 72K | — | $0 |
| Dec 15, 2022 | Handley Daniel E | Director | Buy(P) | 6K | $0.41 | $2K |
| Dec 2, 2022 | Vennare Raymond F | Director | Buy(P) | 400 | $0.52 | $208 |
| Dec 2, 2022 | Vennare Raymond F | Director | Buy(P) | 5K | $0.52 | $2K |
| Dec 2, 2022 | Myers Robert L | CHIEF FINANCIAL OFFICER | Buy(P) | 9K | $0.57 | $5K |
| Dec 1, 2022 | Hawryluk Matthew | Director | Grant(A) | 14K | — | $0 |
| Nov 29, 2022 | Handley Daniel E | Director | Buy(P) | 10K | $0.36 | $4K |
| Nov 1, 2022 | Engle J Melville | Insider | Grant(A) | 213K | — | $0 |
| Oct 25, 2022 | Smith David Stewart | Director | Grant(A) | 19K | — | $0 |
| Oct 3, 2022 | ST. Clair Gregory SR | Director | Grant(A) | 23K | — | $0 |
| Oct 3, 2022 | Nuzum Charles Lee Sr | Director | Grant(A) | 23K | — | $0 |
| Oct 3, 2022 | Handley Daniel E | Director | Grant(A) | 23K | — | $0 |
| Oct 3, 2022 | Chung-Welch Nancy | Director | Grant(A) | 23K | — | $0 |
| Oct 3, 2022 | Vennare Raymond F | Director | Grant(A) | 17K | — | $0 |
| Sep 23, 2022 | Myers Robert L | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 10K | $0.39 | $4K |
| Sep 23, 2022 | Myers Robert L | CHIEF FINANCIAL OFFICER | Option exercise(M) | 33K | — | — |
| Sep 23, 2022 | Myers Robert L | CHIEF FINANCIAL OFFICER | Option exercise(M) | 33K | — | $0 |
| Jul 1, 2022 | Vennare Raymond F | Director | Grant(A) | 32K | — | $0 |
| Jul 1, 2022 | Nuzum Charles Lee Sr | Director | Grant(A) | 45K | — | $0 |
| Jul 1, 2022 | Chung-Welch Nancy | Director | Grant(A) | 45K | — | $0 |
| Jul 1, 2022 | ST. Clair Gregory SR | Director | Grant(A) | 45K | — | $0 |
| Jul 1, 2022 | Handley Daniel E | Director | Grant(A) | 32K | — | $0 |
| Jul 1, 2022 | Jenkins Christina Lee MD | Director | Grant(A) | 32K | — | $0 |
| May 26, 2022 | Handley Daniel E | Director | Buy(P) | 3K | $0.37 | $944 |
| May 25, 2022 | Handley Daniel E | Director | Buy(P) | 3K | $0.35 | $980 |
| May 24, 2022 | Engle J Melville | Director | Buy(P) | 160K | $0.37 | $59K |
| May 20, 2022 | Myers Robert L | CHIEF FINANCIAL OFFICER | Buy(P) | 16K | $0.30 | $5K |
| May 20, 2022 | Nuzum Charles Lee Sr | Director | Buy(P) | 200K | $0.31 | $62K |
| Mar 31, 2022 | Handley Daniel E | Director | Grant(A) | 6K | — | $0 |
| Mar 31, 2022 | Nuzum Charles Lee Sr | Director | Grant(A) | 9K | — | $0 |
| Mar 31, 2022 | ST. Clair Gregory SR | Director | Grant(A) | 6K | — | $0 |
| Mar 31, 2022 | Jenkins Christina Lee MD | Director | Grant(A) | 6K | — | $0 |
| Mar 31, 2022 | Chung-Welch Nancy | Director | Grant(A) | 9K | — | $0 |
| Mar 31, 2022 | Vennare Raymond F | Director | Grant(A) | 6K | — | $0 |
| Jan 4, 2022 | Engle J Melville | CEO and Chairman, Director | Grant(A) | 20K | — | $0 |
| Jan 4, 2022 | Vennare Raymond F | Director | Grant(A) | 15K | — | $0 |
| Jan 4, 2022 | Chung-Welch Nancy | Director | Grant(A) | 32K | — | $0 |
| Jan 4, 2022 | ST. Clair Gregory SR | Director | Grant(A) | 15K | — | $0 |
| Jan 4, 2022 | Handley Daniel E | Director | Grant(A) | 15K | — | $0 |
| Jan 4, 2022 | Nuzum Charles Lee Sr | Director | Grant(A) | 44K | — | $0 |
| Jan 4, 2022 | Jenkins Christina Lee MD | Director | Grant(A) | 15K | — | $0 |
| Oct 1, 2021 | Vennare Raymond F | Director | Grant(A) | 5K | — | $0 |
| Oct 1, 2021 | Nuzum Charles Lee Sr | Director | Grant(A) | 6K | — | $0 |
| Oct 1, 2021 | Jenkins Christina Lee MD | Director | Grant(A) | 5K | — | $0 |
| Oct 1, 2021 | Handley Daniel E | Director | Grant(A) | 5K | — | $0 |
| Oct 1, 2021 | ST. Clair Gregory SR | Director | Grant(A) | 6K | — | $0 |
| Oct 1, 2021 | Engle J Melville | CEO and Chairman, Director | Grant(A) | 5K | — | $0 |
| Oct 1, 2021 | Chung-Welch Nancy | Director | Grant(A) | 5K | — | $0 |
| Sep 23, 2021 | Myers Robert L | Chief Financial Officer | Option exercise(M) | 33K | — | $0 |
| Sep 23, 2021 | Myers Robert L | Chief Financial Officer | Disposed to issuer(D) | 10K | $1.13 | $12K |
| Sep 23, 2021 | Myers Robert L | Chief Financial Officer | Option exercise(M) | 33K | $1.13 | $38K |
| Sep 13, 2021 | Vennare Raymond F | Director | Grant(A) | 5K | — | $0 |
| Jul 1, 2021 | Jenkins Christina Lee MD | Director | Grant(A) | 10K | — | $0 |
| Jul 1, 2021 | Nuzum Charles Lee Sr | Director | Grant(A) | 14K | — | $0 |
| Jul 1, 2021 | ST. Clair Gregory SR | Director | Grant(A) | 14K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).